1. Home
  2. ALLK vs RETO Comparison

ALLK vs RETO Comparison

Compare ALLK & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • RETO
  • Stock Information
  • Founded
  • ALLK 2012
  • RETO 1999
  • Country
  • ALLK United States
  • RETO China
  • Employees
  • ALLK N/A
  • RETO N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • ALLK Health Care
  • RETO Consumer Discretionary
  • Exchange
  • ALLK Nasdaq
  • RETO Nasdaq
  • Market Cap
  • ALLK 22.5M
  • RETO 19.9M
  • IPO Year
  • ALLK 2018
  • RETO 2017
  • Fundamental
  • Price
  • ALLK $0.29
  • RETO $0.41
  • Analyst Decision
  • ALLK Hold
  • RETO
  • Analyst Count
  • ALLK 3
  • RETO 0
  • Target Price
  • ALLK $2.00
  • RETO N/A
  • AVG Volume (30 Days)
  • ALLK 5.6M
  • RETO 3.0M
  • Earning Date
  • ALLK 03-13-2025
  • RETO 10-28-2024
  • Dividend Yield
  • ALLK N/A
  • RETO N/A
  • EPS Growth
  • ALLK N/A
  • RETO N/A
  • EPS
  • ALLK N/A
  • RETO N/A
  • Revenue
  • ALLK N/A
  • RETO $3,841,142.00
  • Revenue This Year
  • ALLK N/A
  • RETO N/A
  • Revenue Next Year
  • ALLK N/A
  • RETO N/A
  • P/E Ratio
  • ALLK N/A
  • RETO N/A
  • Revenue Growth
  • ALLK N/A
  • RETO N/A
  • 52 Week Low
  • ALLK $0.23
  • RETO $0.33
  • 52 Week High
  • ALLK $1.69
  • RETO $3.90
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 33.29
  • RETO 20.99
  • Support Level
  • ALLK $0.28
  • RETO $0.33
  • Resistance Level
  • ALLK $0.33
  • RETO $0.75
  • Average True Range (ATR)
  • ALLK 0.02
  • RETO 0.09
  • MACD
  • ALLK 0.03
  • RETO -0.01
  • Stochastic Oscillator
  • ALLK 55.70
  • RETO 15.74

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: